Brinker Capital Inc. Has $21.55 Million Stake in UnitedHealth Group Inc (NYSE:UNH)

Brinker Capital Inc. raised its position in UnitedHealth Group Inc (NYSE:UNH) by 33.6% during the second quarter, according to its most recent filing with the SEC. The firm owned 73,064 shares of the healthcare conglomerate’s stock after purchasing an additional 18,366 shares during the period. UnitedHealth Group accounts for approximately 0.7% of Brinker Capital Inc.’s portfolio, making the stock its 20th largest position. Brinker Capital Inc.’s holdings in UnitedHealth Group were worth $21,550,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently modified their holdings of UNH. Guggenheim Capital LLC lifted its position in shares of UnitedHealth Group by 5.4% in the 4th quarter. Guggenheim Capital LLC now owns 174,490 shares of the healthcare conglomerate’s stock worth $51,298,000 after purchasing an additional 8,871 shares during the period. Pearl River Capital LLC acquired a new position in shares of UnitedHealth Group during the 4th quarter valued at $288,000. Total Clarity Wealth Management Inc. acquired a new position in shares of UnitedHealth Group during the 4th quarter valued at $34,000. First National Bank of Mount Dora Trust Investment Services lifted its position in shares of UnitedHealth Group by 41.0% during the 1st quarter. First National Bank of Mount Dora Trust Investment Services now owns 17,006 shares of the healthcare conglomerate’s stock valued at $4,241,000 after acquiring an additional 4,945 shares during the period. Finally, Stillwater Investment Management LLC lifted its position in shares of UnitedHealth Group by 26.7% during the 1st quarter. Stillwater Investment Management LLC now owns 1,015 shares of the healthcare conglomerate’s stock valued at $253,000 after acquiring an additional 214 shares during the period. Hedge funds and other institutional investors own 86.44% of the company’s stock.

UNH has been the topic of a number of research reports. Royal Bank of Canada boosted their target price on shares of UnitedHealth Group from $341.00 to $384.00 in a research report on Thursday, July 16th. Cowen boosted their target price on shares of UnitedHealth Group from $320.00 to $340.00 and gave the company an “outperform” rating in a research report on Thursday, April 16th. Oppenheimer boosted their target price on shares of UnitedHealth Group from $343.00 to $353.00 and gave the company an “outperform” rating in a research report on Thursday, July 16th. Stephens boosted their target price on shares of UnitedHealth Group from $325.00 to $335.00 and gave the company an “overweight” rating in a research report on Thursday, July 16th. Finally, Citigroup boosted their target price on shares of UnitedHealth Group from $339.00 to $357.00 and gave the company a “buy” rating in a research report on Thursday, July 16th. One equities research analyst has rated the stock with a sell rating, three have given a hold rating, twenty have issued a buy rating and one has issued a strong buy rating to the stock. UnitedHealth Group presently has a consensus rating of “Buy” and a consensus price target of $338.46.

Shares of NYSE UNH traded down $2.45 during trading on Friday, hitting $302.78. The stock had a trading volume of 3,913,650 shares, compared to its average volume of 2,651,007. UnitedHealth Group Inc has a 12 month low of $187.72 and a 12 month high of $315.84. The company has a debt-to-equity ratio of 0.60, a current ratio of 0.84 and a quick ratio of 0.75. The company has a market capitalization of $287.15 billion, a PE ratio of 17.03, a PEG ratio of 1.45 and a beta of 0.72. The firm has a fifty day moving average of $296.35 and a two-hundred day moving average of $283.67.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Wednesday, July 15th. The healthcare conglomerate reported $7.12 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $5.28 by $1.84. UnitedHealth Group had a net margin of 6.90% and a return on equity of 29.28%. The firm had revenue of $62.10 billion during the quarter, compared to analyst estimates of $63.54 billion. During the same quarter in the prior year, the business posted $3.60 EPS. The business’s revenue was up 2.5% compared to the same quarter last year. On average, equities analysts expect that UnitedHealth Group Inc will post 16.57 earnings per share for the current fiscal year.

In related news, Director Richard T. Burke sold 10,000 shares of the stock in a transaction dated Wednesday, July 22nd. The shares were sold at an average price of $303.50, for a total transaction of $3,035,000.00. Following the completion of the transaction, the director now owns 159,215 shares in the company, valued at $48,321,752.50. The transaction was disclosed in a document filed with the SEC, which is available through this link. Also, CFO John F. Rex sold 22,174 shares of the stock in a transaction dated Friday, July 17th. The shares were sold at an average price of $308.43, for a total transaction of $6,839,126.82. Following the transaction, the chief financial officer now owns 157,847 shares of the company’s stock, valued at approximately $48,684,750.21. The disclosure for this sale can be found here. In the last quarter, insiders sold 136,823 shares of company stock valued at $41,187,284. Company insiders own 0.80% of the company’s stock.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.

Recommended Story: Quiet Period Expirations

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.